Hideaki Fujiwara

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Chronic Obstructive Pulmonary Disease

Magnetic Resonance

Top Venues

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Atsuomi Kimura, Akihiro Shimokawa, Neil James Stewart, Hirohiko Imai, Hideaki Fujiwara
Relationship between Pulmonary Gas Exchange Function and Brain Uptake Dynamics Investigated with Hyperpolarized 129 Xe MR Imaging and Spectroscopy in a Murine Model of Chronic Obstructive Pulmonary Disease. Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine (2024)
Hideaki Fujiwara, Hirohiko Imai, Atsuomi Kimura
Development of stopped-flow hyper-CEST NMR method on recirculating hyperpolarization system as applied to void space analysis in polymers. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry (2024)
Atsuomi Kimura, Seiya Utsumi, Akihiro Shimokawa, Renya Nishimori, Rie Hosoi, Neil James Stewart, Hirohiko Imai, Hideaki Fujiwara
Targeted Imaging of Lung Cancer with Hyperpolarized 129 Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents. Cancers 14 (24) (2022)
Atsuomi Kimura, Seiya Utsumi, Akihiro Shimokawa, Renya Nishimori, Rie Hosoi, Neil James Stewart, Hirohiko Imai, Hideaki Fujiwara
Targeted Imaging of Lung Cancer with Hyperpolarized 129 Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents. Cancers 14 (24) (2022)
Atsuomi Kimura, Seiya Utsumi, Akihiro Shimokawa, Renya Nishimori, Rie Hosoi, Neil James Stewart, Hirohiko Imai, Hideaki Fujiwara
Targeted Imaging of Lung Cancer with Hyperpolarized 129 Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents. Cancers 14 (24) (2022)